Defective removal of ribonucleotides from DNA promotes systemic autoimmunity C Günther, B Kind, MAM Reijns, N Berndt, M Martinez-Bueno, C Wolf, ... The Journal of clinical investigation 125 (1), 413-424, 2015 | 213 | 2015 |
PET/MRI in head and neck cancer: initial experience I Platzek, B Beuthien-Baumann, M Schneider, V Gudziol, J Langner, ... European journal of nuclear medicine and molecular imaging 40, 6-11, 2013 | 163* | 2013 |
RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA C Wolf, A Rapp, N Berndt, W Staroske, M Schuster, M Dobrick-Mattheuer, ... Nature communications 7 (1), 11752, 2016 | 156 | 2016 |
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system C Arndt, A Feldmann, M Von Bonin, M Cartellieri, EM Ewen, S Koristka, ... Leukemia 28 (1), 59-69, 2014 | 88 | 2014 |
“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells N Mitwasi, A Feldmann, C Arndt, S Koristka, N Berndt, J Jureczek, ... Scientific reports 10 (1), 2141, 2020 | 79 | 2020 |
From mono-to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo S Albert, C Arndt, S Koristka, N Berndt, R Bergmann, A Feldmann, ... Oncotarget 9 (39), 25597, 2018 | 65 | 2018 |
Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3′ repair exonuclease 1 (TREX1) C Günther, N Berndt, C Wolf, MA Lee-Kirsch JAMA dermatology 151 (4), 426-431, 2015 | 59 | 2015 |
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy R Aliperta, PB Welzel, R Bergmann, U Freudenberg, N Berndt, ... Scientific reports 7 (1), 42855, 2017 | 58 | 2017 |
Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma C Günther, N Zimmermann, N Berndt, M Großer, A Stein, A Koch, ... The American journal of pathology 179 (3), 1434-1442, 2011 | 58 | 2011 |
Deregulated type I IFN response in TREX1-associated familial chilblain lupus K Peschke, F Friebe, N Zimmermann, T Wahlicht, T Schumann, ... The Journal of investigative dermatology 134 (5), 1456, 2014 | 53 | 2014 |
Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Blood cancer journal 8 (9), 81, 2018 | 46 | 2018 |
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Oncoimmunology 9 (1), 1785608, 2020 | 45 | 2020 |
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells N Mitwasi, A Feldmann, R Bergmann, N Berndt, C Arndt, S Koristka, ... Oncotarget 8 (65), 108584, 2017 | 45 | 2017 |
Conventional CARs versus modular CARs A Feldmann, C Arndt, S Koristka, N Berndt, R Bergmann, MP Bachmann Cancer Immunology, Immunotherapy 68, 1713-1719, 2019 | 42 | 2019 |
Comparison of the stability of Y-90-, Lu-177-and Ga-68-labeled human serum albumin microspheres (DOTA-HSAM) G Wunderlich, E Schiller, R Bergmann, HJ Pietzsch Nuclear medicine and biology 37 (8), 861-867, 2010 | 42 | 2010 |
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells C Arndt, LR Loureiro, A Feldmann, J Jureczek, R Bergmann, D Máthé, ... Oncoimmunology 9 (1), 1743036, 2020 | 32 | 2020 |
Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, D Máthé, ... Journal of Experimental & Clinical Cancer Research 39, 1-13, 2020 | 28 | 2020 |
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR C Arndt, A Feldmann, S Koristka, M Schäfer, R Bergmann, N Mitwasi, ... Oncoimmunology 8 (11), 1659095, 2019 | 27 | 2019 |
SMARCAD1 haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility C Günther, MA Lee-Kirsch, J Eckhard, A Matanovic, T Kerscher, ... The Journal of investigative dermatology 138 (6), 1428-1431, 2018 | 26 | 2018 |
Improved conjugation, 64-cu radiolabeling, in vivo stability, and imaging using nonprotected Bifunctional macrocyclic ligands: Bis (Phosphinate) Cyclam (BPC) Chelators T David, V Hlinová, V Kubicek, R Bergmann, F Striese, N Berndt, ... Journal of Medicinal Chemistry 61 (19), 8774-8796, 2018 | 25 | 2018 |